Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-07-009556
Filing Date
2007-04-30
Accepted
2007-04-30 16:54:35
Documents
4
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K o36017e10vkza.htm 10-K/A 328729
2 EXHIBIT 31.1 o36017exv31w1.htm EX-31.1 2703
3 EXHIBIT 31.2 o36017exv31w2.htm EX-31.2 3033
4 GRAPHIC o36017o3601702.gif GRAPHIC 14030
  Complete submission text file 0000950134-07-009556.txt   355355
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

EIN.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51169 | Film No.: 07801336
SIC: 2834 Pharmaceutical Preparations